These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 26317652)

  • 61. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
    Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
    Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
    [TBL] [Abstract][Full Text] [Related]  

  • 62. NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/β-catenin signaling.
    Kim JT; Kim JW; Kang YH; Kim KD; Lee SJ; Choi SC; Kim KS; Chae SK; Kim JW; Lim JS; Lee HG
    FEBS Lett; 2012 Nov; 586(22):3962-8. PubMed ID: 23068607
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2011; 76():369-74. PubMed ID: 21960526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
    Du K; Chitneni SK; Suzuki A; Wang Y; Henao R; Hyun J; Premont RT; Naggie S; Moylan CA; Bashir MR; Abdelmalek MF; Diehl AM
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):1-21. PubMed ID: 31881361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
    Song Z; Wei B; Lu C; Li P; Chen L
    Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
    Fukuyama R; Niculaita R; Ng KP; Obusez E; Sanchez J; Kalady M; Aung PP; Casey G; Sizemore N
    Oncogene; 2008 Oct; 27(46):6044-55. PubMed ID: 18591935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
    Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
    White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
    Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
    Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
    Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine.
    Sharma SH; Thulasingam S; Chellappan DR; Chinnaswamy P; Nagarajan S
    Eur J Pharmacol; 2017 Feb; 796():20-31. PubMed ID: 27989504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?
    Dang CV
    Cell Cycle; 2010 Oct; 9(19):3884-6. PubMed ID: 20948290
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    Zhang S; Li J; Xie P; Zang T; Shen H; Cao G; Zhu Y; Yue Z; Li Z
    Rejuvenation Res; 2019 Apr; 22(2):138-145. PubMed ID: 29932015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kr-POK (ZBTB7c) regulates cancer cell proliferation through glutamine metabolism.
    Hur MW; Yoon JH; Kim MY; Ko H; Jeon BN
    Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):829-838. PubMed ID: 28571744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
    Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ
    Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter.
    Zhang J; Li F; Liu X; Shen L; Liu J; Su J; Zhang W; Deng Y; Wang L; Liu N; Han W; Zhang J; Ji S; Yang A; Han H; Yao L
    J Biol Chem; 2006 Dec; 281(51):39159-68. PubMed ID: 17050536
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
    Jung Y; Jun Y; Lee HY; Kim S; Jung Y; Keum J; Lee YS; Cho YB; Lee S; Kim J
    Oncotarget; 2015 Sep; 6(28):25368-80. PubMed ID: 26196590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.